Summary by Futu AI
Noubar Afeyan, associated with Moderna, Inc. [MRNA], engaged in a series of stock transactions on June 11, 2024. Afeyan sold a total of 202,832 shares of Moderna's common stock through indirect ownership by Flagship Ventures Fund IV, L.P. and Flagship Ventures Fund IV-Rx, L.P. The sales were executed at prices ranging from $148.2944 to $149.4038, resulting in a total market value of approximately $30,087,338.87. Following these transactions, Afeyan's indirectly held shares in Moderna amounted to 3,924. The sales are reported to be in progress.